BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 32193642)

  • 21. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Ye Q; Ling S; Zheng S; Xu X
    Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid biopsy = Individualized cancer management: Diagnosis, monitoring treatment and checking recurrence and metastasis.
    Mali SB; Dahivelkar S
    Oral Oncol; 2021 Dec; 123():105588. PubMed ID: 34744021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid Biopsy: General Concepts.
    Poulet G; Massias J; Taly V
    Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications.
    Earl J; Calabuig-Fariñas S; Sarasquete ME; Muinelo Romay L; Lopez-Tarruella S; Bellosillo Paricio B; Rodríguez M; Valencia Leoz K; Dueñas Porto M; Tarazona N; Hernandez Losa J; Toledo RA
    J Vis Exp; 2022 Sep; (187):. PubMed ID: 36190291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer.
    Raufi AG; May MS; Hadfield MJ; Seyhan AA; El-Deiry WS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance.
    Kilgour E; Rothwell DG; Brady G; Dive C
    Cancer Cell; 2020 Apr; 37(4):485-495. PubMed ID: 32289272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using Liquid Biopsy in the Treatment of Patient with OS.
    Shulman DS; Crompton BD
    Adv Exp Med Biol; 2020; 1257():95-105. PubMed ID: 32483734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.
    Russano M; Napolitano A; Ribelli G; Iuliani M; Simonetti S; Citarella F; Pantano F; Dell'Aquila E; Anesi C; Silvestris N; Argentiero A; Solimando AG; Vincenzi B; Tonini G; Santini D
    J Exp Clin Cancer Res; 2020 May; 39(1):95. PubMed ID: 32460897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications.
    Shah UJ; Alsulimani A; Ahmad F; Mathkor DM; Alsaieedi A; Harakeh S; Nasiruddin M; Haque S
    Biotechnol Genet Eng Rev; 2022 Oct; 38(2):339-383. PubMed ID: 35968863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.
    Nordgård O; Tjensvoll K; Gilje B; Søreide K
    Br J Surg; 2018 Jan; 105(2):e110-e120. PubMed ID: 29341153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Image-Guided Biopsies and Interventions of Mediastinal Lesions.
    Kooraki S; Abtin F
    Radiol Clin North Am; 2021 Mar; 59(2):291-303. PubMed ID: 33551088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorodeoxyglucose-PET for Ablation Treatment Planning, Intraprocedural Monitoring, and Response.
    Kishore SA; Drabkin MJ; Sofocleous CT
    PET Clin; 2019 Oct; 14(4):427-436. PubMed ID: 31472740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Introduction and Clinical Application of Cell-Free Tumor DNA.
    Li J; Liu R; Huang C; Chen S; Xu M
    Methods Mol Biol; 2018; 1754():45-65. PubMed ID: 29536437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy.
    Kong W; Chen T; Li Y
    Methods Mol Biol; 2023; 2695():127-143. PubMed ID: 37450116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer.
    von Bubnoff N
    Oncol Res Treat; 2017; 40(7-8):409-416. PubMed ID: 28693026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review.
    Chen X; Wang L; Lou J
    Med Sci Monit; 2020 Mar; 26():e921040. PubMed ID: 32200389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The double agents in liquid biopsy: promoter and informant biomarkers of early metastases in breast cancer.
    Richard V; Davey MG; Annuk H; Miller N; Kerin MJ
    Mol Cancer; 2022 Apr; 21(1):95. PubMed ID: 35379239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid Biopsies for Neuroendocrine Tumors: Circulating Tumor Cells, DNA, and MicroRNAs.
    Rizzo FM; Meyer T
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):471-483. PubMed ID: 30098711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liquid biopsy: novel technologies and clinical applications.
    Reimers N; Pantel K
    Clin Chem Lab Med; 2019 Feb; 57(3):312-316. PubMed ID: 30465714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.